{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:37:19Z","timestamp":1772253439922,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.japh.2016.02.012","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T07:02:24Z","timestamp":1458802944000},"page":"248-256.e6","source":"Crossref","is-referenced-by-count":28,"title":["Prescription opioid use: Patient characteristics and misuse in community pharmacy"],"prefix":"10.1016","volume":"56","author":[{"given":"Gerald","family":"Cochran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ylioja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Hruschak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Seybert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Tarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.japh.2016.02.012_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective","volume":"12","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"key":"10.1016\/j.japh.2016.02.012_bib2","series-title":"Results from the 2012 national survey on drug use and health: summary of national findings","year":"2013"},{"key":"10.1016\/j.japh.2016.02.012_bib3","series-title":"Morbidity and mortality weekly report. Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008","year":"2011"},{"issue":"2 suppl","key":"10.1016\/j.japh.2016.02.012_bib4","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.36076\/ppj.2008\/11\/S63","article-title":"Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Physician"},{"issue":"12","key":"10.1016\/j.japh.2016.02.012_bib5","first-page":"897","article-title":"Analytic models to identify patients at risk for prescription opioid abuse","volume":"15","author":"White","year":"2009","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.japh.2016.02.012_bib7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1526-4637.2012.01450.x","article-title":"A\u00a0model to identify patients at risk for prescription opioid abuse, dependence, and misuse","volume":"13","author":"Rice","year":"2012","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.japh.2016.02.012_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2007.09.018","article-title":"Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates","volume":"94","author":"Becker","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.japh.2016.02.012_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/070674371105600808","article-title":"Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review","volume":"56","author":"Amari","year":"2011","journal-title":"Can J Psychiatry"},{"issue":"10","key":"10.1016\/j.japh.2016.02.012_bib10","first-page":"729","article-title":"Screening for potential prescription opioid misuse in a Michigan Medicaid population","volume":"41","author":"Braker","year":"2009","journal-title":"Fam Med"},{"issue":"1\u20132","key":"10.1016\/j.japh.2016.02.012_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2008.09.013","article-title":"Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States","volume":"100","author":"Novak","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.japh.2016.02.012_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpainsymman.2007.10.003","article-title":"Epidemiology of regular prescribed opioid use: results from a national, population-based survey","volume":"36","author":"Hudson","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.japh.2016.02.012_bib13","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","year":"2009"},{"key":"10.1016\/j.japh.2016.02.012_bib14","series-title":"Underlying cause of death 1999\u20132013 on CDC Wonder online database, released 2015","year":"2015"},{"key":"10.1016\/j.japh.2016.02.012_bib15","unstructured":"Centers for Disease Control and Prevention. Prescription drug overdose data: deaths from prescription opioid overdose. Available at http:\/\/www.cdc.gov\/drugoverdose\/data\/overdose.html. Accessed July 16,\u00a02015."},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00952990601175078","article-title":"Differences in prevalence of prescription opiate misuse among rural and urban probationers","volume":"33","author":"Havens","year":"2007","journal-title":"Am J\u00a0Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.japh.2016.02.012_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J\u00a0Pharm Pract"},{"issue":"3","key":"10.1016\/j.japh.2016.02.012_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/00952990.2011.643971","article-title":"A\u00a0comparison of rural and urban nonmedical prescription opioid users' lifetime and recent drug use","volume":"38","author":"Young","year":"2012","journal-title":"Am J\u00a0Drug Alcohol Abuse"},{"key":"10.1016\/j.japh.2016.02.012_bib19","unstructured":"Centers for Disease Control and Prevention. Policy impact: prescription drug overdose state rates. Available at http:\/\/www.cdc.gov\/HomeandRecreationalSafety\/rxbrief\/states.html. Accessed December 7,\u00a02011."},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0897190014522064","article-title":"Pharmacists who screen and discuss opioid misuse with patients: future directions for research and practice","volume":"28","author":"Cochran","year":"2014","journal-title":"J\u00a0Pharm Pract"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jphs.12013","article-title":"Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists","volume":"4","author":"Cochran","year":"2013","journal-title":"J\u00a0Pharm Health Serv Res"},{"key":"10.1016\/j.japh.2016.02.012_bib23","unstructured":"Cochran G, Erickson C, Field C, et\u00a0al. Prescription opioid misuse and Texas pharmacies. Bethesda, MD: Association for Medical Education and Research in Substance Abuse Annual Conference; November\u00a02013."},{"key":"10.1016\/j.japh.2016.02.012_bib24","unstructured":"Cochran G, Field C, Lawson K, et\u00a0al. Rx opioid abuse: the role of pharmacists. Palm Springs, CA: College on Problems of Drug Dependence Annual Meeting; June\u00a02012."},{"issue":"21","key":"10.1016\/j.japh.2016.02.012_bib25","first-page":"2","article-title":"Pharmacists receive high marks on trust","volume":"34","year":"2012","journal-title":"Chain Drug Rev"},{"key":"10.1016\/j.japh.2016.02.012_bib26","series-title":"Select features of state pharmacist collaborative practice laws","year":"2013"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1526-4637.2006.00255.x","article-title":"Mechanisms of prescription drug diversion among drug-involved club and street-based populations","volume":"8","author":"Inciardi","year":"2007","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/002204261104100207","article-title":"Multiple determinants of specific modes of prescription opioid diversion","volume":"41","author":"Cicero","year":"2011","journal-title":"J\u00a0Drug Issues"},{"issue":"5","key":"10.1016\/j.japh.2016.02.012_bib29","first-page":"411","article-title":"Screening community pharmacy patients for risk of prescription opioid misuse","volume":"9","author":"Cochran","year":"2015","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.japh.2016.02.012_bib30","unstructured":"Cochran G, Rubinstein J, Bacci JL, et\u00a0al. Community pharmacy and opioid pain medication: screening patients who misuse or are at risk for misuse. Association for Medical Education and Research in Substance Abuse Annual Conference; November\u00a02015."},{"key":"10.1016\/j.japh.2016.02.012_bib31","series-title":"Substate estimates of substance use and mental disorders from the 2010\u20132012 national surveys on drug use and health: results and detailed tables","year":"2014"},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jsat.2008.02.001","article-title":"Prescription opioid misuse index: a brief questionnaire to assess misuse","volume":"35","author":"Knisely","year":"2008","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A\u00a0comprehensive review of the psychometric properties of the Drug Abuse Screening Test","volume":"32","author":"Yudko","year":"2007","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.japh.2016.02.012_bib34","unstructured":"Skinner HA. Guide for using the Drug Abuse Screening Test (DAST). York University, Toronto."},{"issue":"3","key":"10.1016\/j.japh.2016.02.012_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1360-0443.1989.tb03463.x","article-title":"Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders","volume":"84","author":"Gavin","year":"1989","journal-title":"Br J Addict"},{"issue":"9","key":"10.1016\/j.japh.2016.02.012_bib36","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1530-0277.2012.01761.x","article-title":"Variation in documented care for unhealthy alcohol consumption across race\/ethnicity in the Department of Veterans Affairs Healthcare System","volume":"36","author":"Williams","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"16","key":"10.1016\/j.japh.2016.02.012_bib37","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.japh.2016.02.012_bib38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.japh.2016.02.012_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2753.2010.01623.x","article-title":"Construct validity of the SF-12 in three different samples","volume":"18","author":"Jakobsson","year":"2012","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.japh.2016.02.012_bib40","series-title":"A\u00a0guide to the integration of certified Short Form survey scoring and data quality evaluation capabilities","author":"Maruish","year":"2009"},{"issue":"11","key":"10.1016\/j.japh.2016.02.012_bib41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"11 pt 2","key":"10.1016\/j.japh.2016.02.012_bib42","first-page":"839","article-title":"Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item","volume":"10","author":"Corson","year":"2004","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsat.2010.05.005","article-title":"Validation of the Primary Care Posttraumatic Stress Disorder screening questionnaire (PC-PTSD) in civilian substance use disorder patients","volume":"39","author":"van Dam","year":"2010","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.janxdis.2007.02.010","article-title":"Identifying PTSD in primary care: comparison of the Primary Care\u2013PTSD Screen (PC-PTSD) and the General Health Questionnaire-12 (GHQ)","volume":"22","author":"Ouimette","year":"2008","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.japh.2016.02.012_bib45","first-page":"99","article-title":"The Primary Care PTSD screen (PC-PTSD): development and operating characteristics","volume":"9","author":"Prins","year":"2003","journal-title":"Prim Care Psychiatry"},{"key":"10.1016\/j.japh.2016.02.012_bib46","series-title":"Stata SE","year":"2015"},{"issue":"1","key":"10.1016\/j.japh.2016.02.012_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13181-012-0285-4","article-title":"Fentanyl-associated fatalities among illicit drug users in Wayne County, Michigan (July 2005\u2013May 2006)","volume":"9","author":"Algren","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.japh.2016.02.012_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugalcdep.2015.06.020","article-title":"Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?","volume":"154","author":"Betts","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.japh.2016.02.012_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1521-0391.2011.00120.x","article-title":"Oxycodone abuse in New York City: characteristics of intravenous and intranasal users","volume":"20","author":"Jones","year":"2011","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2004.05.001","article-title":"Substance use histories in patients seeking treatment for controlled-release oxycodone dependence","volume":"76","author":"Potter","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib51","first-page":"758","article-title":"Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities","volume":"92","author":"Visconti","year":"2015","journal-title":"J\u00a0Urban Health"},{"issue":"1\u20133","key":"10.1016\/j.japh.2016.02.012_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2012.06.027","article-title":"Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents","volume":"127","author":"Wang","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11606-012-2225-z","article-title":"Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact. Utah, 2008\u20132009","volume":"28","author":"Johnson","year":"2013","journal-title":"J\u00a0Gen Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.japh.2016.02.012_bib55","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1526-4637.2011.01134.x","article-title":"An analysis of the root causes for opioid-related overdose deaths in the United States","volume":"12","author":"Webster","year":"2011","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib56","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.36076\/ppj.2014\/17\/E119","article-title":"Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011","volume":"17","author":"Atluri","year":"2014","journal-title":"Pain Physician"},{"issue":"5","key":"10.1016\/j.japh.2016.02.012_bib57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1081\/JA-200030572","article-title":"A\u00a0validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache","volume":"43","author":"Schuckman","year":"2008","journal-title":"Subst Use Misuse"},{"issue":"8","key":"10.1016\/j.japh.2016.02.012_bib58","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1377\/hlthaff.2013.1398","article-title":"The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs","volume":"33","author":"Pringle","year":"2014","journal-title":"Health Aff"},{"issue":"6","key":"10.1016\/j.japh.2016.02.012_bib59","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s11096-013-9845-1","article-title":"Alcohol brief intervention in community pharmacies: a feasibility study of outcomes and customer experiences","volume":"35","author":"Khan","year":"2013","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"10.1016\/j.japh.2016.02.012_bib60","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1331\/JAPhA.2014.14034","article-title":"Implementation of targeted medication adherence interventions within a community chain pharmacy practice: the Pennsylvania Project","volume":"54","author":"Bacci","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1331\/154434504773062618","article-title":"Impact and feasibility of a community pharmacy bone mineral density screening and education program","volume":"44","author":"Cerulli","year":"2004","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2016.02.012_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.sapharm.2015.05.001","article-title":"Developing a framework of care for opioid medication misuse in community pharmacy","volume":"12","author":"Cochran","year":"2016","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.japh.2016.02.012_bib63","series-title":"PQA performance measures","year":"2015"},{"issue":"4","key":"10.1016\/j.japh.2016.02.012_bib64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1331\/JAPhA.2012.10214","article-title":"Recovering substance-impaired pharmacists' views regarding occupational risks for addiction","volume":"52","author":"Merlo","year":"2012","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2016.02.012_bib65","unstructured":"American Association of Colleges of Pharmacy. Substance abuse: the pharmacy educator's role in prevention and recovery. Guidelines for the development of addiction and related disorders policies for colleges and schools of pharmacy. Alexandria, VA: American Association of Colleges of Pharmacy."},{"key":"10.1016\/j.japh.2016.02.012_bib66","unstructured":"Code of Federal Regulations, US. Federal register volume 79, number 163;\u00a02014."}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T03:11:29Z","timestamp":1655349089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319116001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1544319116001230"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2016.02.012","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}